Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-14 Sale |
2025-02-18 5:40 pm |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
7,134 | $8.7559 | $62,465 | 138,187 (Direct) |
View |
| 2024-06-14 Sale |
2024-06-18 5:58 pm |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
63,358 | $46.57 | $2,950,518 | 308,403 (Direct) |
View |
| 2022-08-10 Purchase |
2022-08-11 09:55 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
3,800 | $0.264 | $1,003 | 98,230 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-16 10:41 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
10,500 | $0.25 | $2,625 | 94,430 (Direct) |
View |
| 2022-03-09 Purchase |
2022-03-09 10:37 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
8,600 | $0.37 | $3,182 | 83,930 (Direct) |
View |
| 2020-11-11 Purchase |
2020-11-12 10:28 am |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
4,240 | $1.209 | $5,126 | 75,330 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-31 Option Award |
2025-02-04 5:11 pm |
N/A 2035-01-31 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
296,900 | $0 | 374,121 (Direct) |
View |
| 2024-06-17 Exercise |
2024-06-18 5:58 pm |
N/A N/A |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
21,000 | $30 | 308,403 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 5:58 pm |
N/A N/A |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
18,600 | $14.1 | 308,403 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 5:58 pm |
2023-02-01 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
56,179 | $0 | 308,403 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 5:58 pm |
N/A N/A |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
16,579 | $4.26 | 308,403 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 3:19 pm |
N/A 2034-02-12 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
73,947 | $0 | 158,347 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 4:56 pm |
2014-02-28 2014-01-29 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
7,179 | $4.97 | 7,179 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 12:44 pm |
N/A 2033-02-13 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
1,989,546 | $0 | 1,949,546 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:51 pm |
N/A 2032-02-01 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
1,489,700 | $0 | 1,489,700 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 4:35 pm |
N/A 2031-02-02 |
Corbus Pharmaceuticals Holdings Inc. | CRBP | Cohen Yuval Chief Executive Officer |
1,913,000 | $0 | 1,913,000 (Direct) |
View |